The Hanover Insurance Group, Inc. (THG) Stock Price & Analysis
The Hanover Insurance Group, Inc. (THG) closed at USD 228.42 on Thursday, October 15, 2026, up 0.99% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 226.17; the Oct 15, 2026 session ranged USD 227.87–231.38 on volume of 238,655 shares. Market capitalization is $7.95B, with a 52-week range of USD 166.54–236.07 (NYQ). Source: Nexqual, retrieved October 16, 2026 at 05:22 UTC.
Also available as compact Markdown for AI agents: nexqual.com/THG.md
Key facts (THG)
- 1 of 80 tracked superinvestors hold THG (13F, Q2 2026): 0 new, 0 added, 0 reduced, 1 unchanged.
- Analysts: Hold (mean 2.63 on a 1–5 scale) (8 analysts), mean target USD 235.88 (range 223–260).
- Total return with dividends: 1Y +38.3% vs S&P 500 +18.1%; 5Y +90.9% vs S&P 500 +85.1%.
- Next earnings: 2026-10-28, EPS estimate USD 4.57, revenue estimate $1.80B.
Superinvestors (SEC 13F-HR, Q2 2026) (THG)
1 of 80 tracked investors hold THG. Change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Thomas Gayner | Markel Group | 0.46% | $60.2M | Unchanged |
Analysts (THG)
Consensus Hold (mean 2.63 on a 1–5 scale), 8 analysts; mean target USD 235.88 (low 223, high 260).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-06 | Morgan Stanley | Target lowered | Equal-Weight | $240 → $230 |
| 2026-09-18 | Keefe, Bruyette & Woods | Target raised | Market Perform | $222 → $232 |
| 2026-08-19 | Morgan Stanley | Target raised | Equal-Weight | $235 → $240 |
| 2026-08-06 | Keefe, Bruyette & Woods | Target raised | Market Perform | $220 → $222 |
| 2026-07-30 | RBC Capital | Target raised | Sector Perform | $215 → $235 |
| 2026-07-29 | Citizens | Target raised | Market Outperform | $225 → $240 |
| 2026-07-15 | Piper Sandler | Downgrade | Overweight → Neutral | $220 |
| 2026-07-13 | RBC Capital | Target raised | Sector Perform | $195 → $215 |
| 2026-07-10 | Citizens | Target raised | Market Outperform | $205 → $225 |
| 2026-07-08 | Morgan Stanley | Target raised | Equal-Weight | $220 → $225 |
| 2026-07-08 | Keefe, Bruyette & Woods | Downgrade | Outperform → Market Perform | $211 → $220 |
| 2026-07-06 | Morgan Stanley | Target raised | Equal-Weight | $195 → $220 |
Total return (dividends reinvested) (THG)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | +38.3% | +90.9% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +38.4% | +13.8% |
| Volatility (annualized) | 20.5% | 22.2% |
| Max drawdown | -10.0% (Dec 2025→Jan 2026) | -30.1% (Mar 2022→Sep 2023) |
Key Statistics (as of October 16, 2026 at 05:22 UTC)
| Price | USD 228.42 |
|---|---|
| Change | ▲ 0.99% (up) |
| Previous Close | USD 226.17 |
| Open | USD 229.82 |
| Day Range | USD 227.87 – 231.38 |
| 52-Week Range | USD 166.54 – 236.07 |
| Volume | 238,655 shares |
| Market Cap | $7.95B |
| Exchange | NYQ |
Technical Analysis (THG)
Nexqual's technical model rates THG "BUY" based on 5 bullish and 2 bearish signals across 127 daily candles, as of October 16, 2026 at 05:22 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 60.5 (neutral) |
| vs SMA50 | Above (USD 223.9) |
| MACD | 0.19 (positive) |
Analyst Ratings (THG)
Wall Street analysts rate THG "Hold" based on 8 analysts, with a mean price target of USD 235.88 (range USD 223–260), per Nexqual as of October 16, 2026 at 05:22 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 8 |
| Mean Target | USD 235.88 |
| High Target | USD 260 |
| Low Target | USD 223 |
| Buy / Hold / Sell | 2 / 6 / 0 |
Earnings (THG)
| Next Earnings Date | 2026-10-28 |
|---|---|
| EPS Estimate | USD 4.57 |
| Revenue Estimate | $1.80B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 5.31 vs est 3.76 ▲ beat |
| 2026-03-31 | USD 5.25 vs est 4.22 ▲ beat |
| 2025-12-31 | USD 5.79 vs est 5.03 ▲ beat |
| 2025-09-30 | USD 5.09 vs est 4.22 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Financials & Fundamentals (THG)
| Total Revenue | $6.76B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +4.30% |
| Gross Margin | +25.19% |
| Operating Margin | +14.75% |
| Profit Margin | +11.17% |
| ROE | +21.88% |
| Debt / Equity | 0.23 |
| Current Ratio | 0.36 |
| Total Cash | $266.10M |
| Total Debt | $844.00M |
| Free Cash Flow (fiscal year ended Dec 2025, SEC 10-K) | $1.17B (17.7% of revenue) |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Financial Health Score (THG)
Nexqual rates The Hanover Insurance Group, Inc.'s overall financial health "Solid" across five dimensions, as of October 16, 2026 at 05:22 UTC.
| Growth | Mixed — Revenue +3.9% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 25%, operating 15% |
| Balance Sheet | Solid — $266M cash vs $844M debt |
| Cash Flow | Strong — FCF $1.17B (FY ended Dec 2025, 10-K), 18% margin |
| Efficiency | Strong — ROE 22%, ROA 3.9% |
Ownership (THG)
| Insider Ownership | +0.95% |
|---|---|
| Institutional Ownership | +93.39% |
| Shares Outstanding | 34.82M |
| Float | 34.46M |
| Short % of Float | +3.35% |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Leadership (THG)
The Hanover Insurance Group, Inc. is led by John Conner Roche (age 61), President, CEO & Director, per Nexqual as of October 16, 2026 at 05:22 UTC.
| President, CEO & Director | John Conner Roche (age 61) |
|---|---|
| Executive VP & CFO | Jeffrey Mark Farber (age 60) |
| Executive VP & COO | Richard William Lavey (age 57) |
| Executive VP & President of Specialty | Bryan James Salvatore (age 60) |
| Senior Vice President of Corporate Finance | Oksana Lukasheva |
Major Backers & Investors (THG)
Notable institutional backers of The Hanover Insurance Group, Inc. include Price (T.Rowe) Associates Inc, American Century Companies Inc, AQR Capital Management, LLC, according to Nexqual as of October 16, 2026 at 05:22 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Price (T.Rowe) Associates Inc | 5.26% |
| American Century Companies Inc | 5.15% |
| AQR Capital Management, LLC | 3.85% |
| Fuller & Thaler Asset Management Inc. | 3.13% |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 2.99% |
| Alliancebernstein L.P. | 2.61% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 17.1% |
| BlackRock | 13.67% |
| State Street | 4.67% |
| Dimensional Fund Advisors | 2.96% |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KNSL | Kinsale Capital Group, Inc. | USD 357.49 | ▲ 5.15% |
| ORI | Old Republic International Corp | USD 38.67 | ▲ 1.36% |
| RLI | RLI Corp. | USD 59.48 | ▲ 4.17% |
| AFG | American Financial Group, Inc. | USD 145.73 | ▲ 0.77% |
| SIGI | Selective Insurance Group, Inc. | USD 87.3 | ▲ 2.52% |
| WTM | White Mountains Insurance Group | USD 2,143.73 | ▲ 2.42% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:22 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt